Healthcare -
Biotechnology - NASDAQ - US
$ 9.705
0.674 %
$ 2.9 B
Market Cap
-28.54
P/E
FOLD - LONG-TERM INVESTMENTS
Long-term Investments FOLD - Amicus Therapeutics, Inc.
0
LAST VALUE
41.42%
2 YEAR CAGR
14.87%
5 YEAR CAGR
0.00%
10 YEAR CAGR